PharmaS

PharmaS is a Croatian pharmaceutical company that was founded in 2008 with a mission to revolutionize the healthcare industry. The company operates across seven countries in the Southeastern European (SEE) markets and has recently expanded its operations into Western European markets with the acquisition of Madrid-based MABO-FARMA in 2023. With a diverse portfolio of Rx retail and hospital products, OTC drugs, and consumer healthcare offerings, PharmaS has positioned itself as a leading player in the Adria region.

Employing over 400 experts, including 150 customer-facing staff, PharmaS has built strong commercial operations in its target markets. The company's strategic focus on becoming a pan-European pharma company is underscored by its strong partnership network and collaborations with various pharmaceutical companies for the commercialization of drugs. Notably, PharmaS owns three state-of-the-art pharmaceutical factories located in Croatia and Serbia, with a combined annual production capacity of over 30 million packages.

PharmaS is committed to maintaining the highest standards of quality and compliance in its manufacturing and distribution processes, conforming to EU regulations and GMP (Good Manufacturing Practice) standards. This dedication to quality has been recognized through various certifications, including ISO 21000:2005 and HACCP compliance for food supplement production. The company's unwavering commitment to quality has garnered accolades from auditors and regulatory authorities, positioning PharmaS as the first Croatian pharmaceutical company to be inspected under the EU's TAIEX program and receive excellent ratings.

The strong market presence, robust manufacturing capabilities, and unwavering commitment to quality have positioned PharmaS as a formidable player in the pharmaceutical industry, poised for further growth and success in both SEE and Western European markets.